Functional magnetic resonance imaging of tonic pain and vasopressor effects in rats.
In functional magnetic resonance imaging (fMRI) studies, an elevation in blood pressure (BP) in individuals with a poor autoregulatory response may increase cerebral blood flow, potentially enhancing the blood oxygenation level dependent response. To investigate the role of BP changes, the cerebral activation to either tonic pain or the infusion of the vasopressor norepinephrine was correlated with the accompanying BP changes in alpha-chloralose anesthetized rats. Immediately after formalin (2%) injection into the forepaw, fMRI detected an activation that was correlated with the BP increase and additional activations that were independent of blood pressure changes 5-40 minutes later. The activation detected with the administration of the vasopressor norepinephrine, which does not cross the blood-brain barrier was correlated to both the amount and rate of increase in BP. The response ranged from being sparse, localized within cortex or widespread during modest, moderate or severe elevations in BP, respectively. The cerebral circulatory effects of hypertension should be considered as contributing to changes in cerebral blood oxygenation in fMRI studies involving increases in BP.
Tuor
U I
UI
Institute for Biodiagnostics (West), National Research Council of Canada, Calgary, Alberta, Canada. ursula.tuor@nrc.ca
McKenzie
E
E
Tomanek
B
B
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000502:physiology*; D002560:Cerebrovascular Circulation; D005557:Formaldehyde; D008279:Magnetic Resonance Imaging; D009020:Morphine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010100:Oxygen / Q000097:blood; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000701:Analgesics, Opioid; D014662:Vasoconstrictor Agents; D005557:Formaldehyde; D009020:Morphine; D010100:Oxygen; D009638:Norepinephrine